Jakub Fichna
Jakub Fichna
Medical University of Lodz, Poland
Verified email at - Homepage
Cited by
Cited by
The role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases
A Piechota-Polanczyk, J Fichna
Naunyn-Schmiedeberg's archives of pharmacology 387, 605-620, 2014
Opioid receptors and their ligands
A Janecka, J Fichna, T Janecki
Current topics in medicinal chemistry 4 (1), 1-17, 2004
The endomorphin system and its evolving neurophysiological role
J Fichna, A Janecka, J Costentin, JC Do Rego
Pharmacological reviews 59 (1), 88-123, 2007
The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders
K Socała, U Doboszewska, A Szopa, A Serefko, M Włodarczyk, ...
Pharmacological Research 172, 105840, 2021
Distribution, function and physiological role of melatonin in the lower gut
CQ Chen, J Fichna, M Bashashati, YY Li, M Storr
World journal of gastroenterology: WJG 17 (34), 3888, 2011
Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives
M Sobczak, M Sałaga, MA Storr, J Fichna
Journal of gastroenterology 49, 24-45, 2014
Synthesis of target-specific radiolabeled peptides for diagnostic imaging
J Fichna, A Janecka
Bioconjugate chemistry 14 (1), 3-17, 2003
Beneficial effects of probiotics, prebiotics, synbiotics, and psychobiotics in inflammatory bowel disease
A Wasilewski, M Zielińska, M Storr, J Fichna
Inflammatory bowel diseases 21 (7), 1674-1682, 2015
Brain-gut interactions in IBS
J Fichna, MA Storr
Frontiers in pharmacology 3, 127, 2012
The role of morphine in regulation of cancer cell growth
K Gach, A Wyrębska, J Fichna, A Janecka
Naunyn-Schmiedeberg's archives of pharmacology 384, 221-230, 2011
Natural and synthetic α-methylenelactones and α-methylenelactams with anticancer potential
A Janecka, A Wyrębska, K Gach, J Fichna, T Janecki
Drug Discovery Today 17 (11-12), 561-572, 2012
LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity
A Fabisiak, N Murawska, J Fichna
Pharmacological Reports 68 (4), 802-808, 2016
Effects of berberine in the gastrointestinal tract—a review of actions and therapeutic implications
C Chen, Z Yu, Y Li, J Fichna, M Storr
The American journal of Chinese medicine 42 (05), 1053-1070, 2014
A randomized clinical trial of berberine hydrochloride in patients with diarrhea‐predominant irritable bowel syndrome
C Chen, C Tao, Z Liu, M Lu, Q Pan, L Zheng, Q Li, Z Song, J Fichna
Phytotherapy research 29 (11), 1822-1827, 2015
Polyphenols as mitochondria-targeted anticancer drugs
S Gorlach, J Fichna, U Lewandowska
Cancer Letters 366 (2), 141-149, 2015
Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review
M Sałaga, H Zatorski, M Sobczak, C Chen, J Fichna
Current treatment options in oncology 15, 405-420, 2014
Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases
M Sobczak, A Fabisiak, N Murawska, E Wesołowska, P Wierzbicka, ...
Pharmacological Reports 66 (5), 766-775, 2014
Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH)
M Sałaga, A Mokrowiecka, PK Zakrzewski, A Cygankiewicz, E Leishman, ...
Journal of Crohn's and Colitis 8 (9), 998-1009, 2014
Polyunsaturated fatty acids and their derivatives: therapeutic value for inflammatory, functional gastrointestinal disorders, and colorectal cancer
A Michalak, P Mosińska, J Fichna
Frontiers in pharmacology 7, 225067, 2016
Anemia of chronic disease and iron deficiency anemia in inflammatory bowel diseases: pathophysiology, diagnosis, and treatment
N Murawska, A Fabisiak, J Fichna
Inflammatory bowel diseases 22 (5), 1198-1208, 2016
The system can't perform the operation now. Try again later.
Articles 1–20